TV3, RTVE, Rac1, La Vanguardia, and Ara, among other important media, have published articles about research led by Eduard Batlle, head of the Colorectal Cancer Laboratory at IRB Barcelona, on the effectiveness of treatments that enhance immune system function in colon cancer.
Link to ABC
Link to El Punt Avui
A team headed by ICREA researcher Eduard Batlle discovers that immune system-stimulating treatments combined with a TGF-beta inhibitor are effective against colon cancer.
The researchers developed a mouse model that mimics advanced human colon cancer. This model has allowed them to study the immune system response for the first time.
The science news portal Madri+d echoes on the release of the video “Meet Our Scientists” about the research into colon cancer conducted by Eduard Batlle, ICREA researcher at IRB Barcelona.
The Madri+d news bulletin reaches more than 60,000 subscribers.
ICREA research professor Eduard Batlle is featured in the “Meet Our Scientists” video entitled “Deconstructing colon cancer”.
The video presents IRB Barcelona's Colorectal Cancer Laboratory research, which is devoted to understanding the behaviour of colon tumours and propose new cures for patients.
The newspaper "ARA" reports on the award of the XI Francisco Cobos Foundation Prize for Excellence in Biomedical Research to ICREA researcher Eduard Batlle, coordinator of the Oncology Programme and head of the Colorectal Cancer Laboratory at IRB Barcelona.
The article also includes the jury's acknowledgment of his contribution to knowledge of colorectal cancer and the potential of his research to generate new treatments and diagnostic tools for this disease.
Selected Media Mentions
Link to Diari ARA
The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.The foundation, which is based in Madrid, awards Batlle for his research of excellence on colon cancer—one of the tumours with greatest prevalence worldwide.
The project, headed by group leader and ICREA researcher Eduard Batlle, receives a 60,000-€ grant.
The study will test the effectiveness of immunotherapies to treat metastatic disease in advanced colorectal cancer.
Research will take place during the academic years 2017 and 2018.
On May 13, IRB Barcelona will be holding its Open Day, from 10:00 to 15:00, and almost all the places have been reserved.
Audiences of all ages will visit the laboratories, participate in workshops, and attend informative talks at the Institute, which is located in the Barcelona Science Park.
In EMBO Molecular Medicine, IRB Barcelona scientists report a technique based on a combination of CRISPR/Cas9 genome editing and patient-derived tumour organoids that allows the study of cell heterogeneity in human tumours.
The novel approach was used to examine the behaviour of colorectal cancer stem cells by tracing specific marker genes.
ACCIÓ awards the Institute’s Innovation Department with the quality seal TECNIO and two VALUNI grants for technology transfer projects